In 2026, a new machine called the Augma is developed to compete against the NerveGear and its successor, the Amusphere. A next-gen wearable device, the Augma doesn't have a full-dive function like its predecessors. Instead, it uses Augmented Reality to get players into the game. It is safe, user-friendly and lets users play while they are conscious, making it an instant hit on the market. The most popular game on the system is “Ordinal Scale” an ARMMORPG developed exclusively for the Augma. Asuna and the gang have already been playing OS for a while, by the time Kirito decides to join them. They’re about to find out that Ordinal Scale isn’t all fun and games…
In 2026, a new machine called the Augma is developed to compete against the NerveGear and its successor, the Amusphere. A next-gen wearable device, the Augma doesn't have a full-dive function like its predecessors. Instead, it uses Augmented Reality to get players into the game. It is safe, user-friendly and lets users play while they are conscious, making it an instant hit on the market. The most popular game on the system is “Ordinal Scale” an ARMMORPG developed exclusively for the Augma. Asuna and the gang have already been playing OS for a while, by the time Kirito decides to join them. They’re about to find out that Ordinal Scale isn’t all fun and games…
Top Cast
Yoshitsugu Matsuoka
Character: Kazuto Kirigaya / Kirito (voice)
Haruka Tomatsu
Character: Asuna Yūki (voice)
Kanae Itou
Character: Yui (voice)
Ayana Taketatsu
Character: Suguha Kirigaya / Leafa (voice)
Rina Hidaka
Character: Keiko Ayano / Silica (voice)
Ayahi Takagaki
Character: Rika Shinozaki / Lizbeth (voice)
Miyuki Sawashiro
Character: Shino Asada / Sinon (voice)
Hiroaki Hirata
Character: Klein (voice)
Hiroki Yasumoto
Character: Andrew Gilbert Mills / Agil (voice)
A platform for film enthusiasts to discover entertainment content. Always verify content ownership through official channels.
Our service indexes publicly available web resources similarly to search engines. All trademarks and content rights remain with their respective holders. For takedown requests, please contact the originating sources directly.